Distal vs. Conventional Transradial Access in Patients With STEMI: Primary Outcomes of the DR-STEMI Randomized Trial
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Pfizer; Boehringer Ingelheim; Chiesi; Abbott</li><li>Grant Support/Research Contract - Terumo Medical Corporation</li></ul>